Purification of non-human antibodies using kosmotropic salt enhanced protein a affinity chromatography
OwnerChen Wang, Susan E. Lacy +1inventors
InventorsChen Wang, Susan E. Lacy, Randolph Huelsman
Life of this patent
Estimating the term…
Loading patent…
OwnerChen Wang, Susan E. Lacy +1inventors
InventorsChen Wang, Susan E. Lacy, Randolph Huelsman
Estimating the term…
The present invention is directed to methods for purifying a non-human antibody, or antigen binding portion thereof, exhibiting weak binding strength and low binding capacity for Protein A chromatography media. In one aspect, a kosmotropic salt solution is employed to promote the hydrophobic interaction between the non-human antibody, or antigen binding portion thereof, and the Protein A ligand, thereby enhancing the binding of the non-human antibody, or antigen binding portion thereof, to the Protein A chromatography media. In another aspect, the concentration of the non-human antibody, or antigen binding portion thereof, in a sample comprising the antibody, or antigen binding portion thereof, exposed to a Protein A chromatography media is increased to enhance the binding of the non-human antibody, or antigen binding portion thereof, on the Protein A chromatography media.
A method for producing a preparation comprising a non-human antibody, or antigen binding portion thereof, and having a reduced level of at least one impurity, said method comprising:
3-6. (canceled)
8-12. (canceled)
(canceled)
16-27. (canceled)
29-31. (canceled)
34-36. (canceled)
38-39. (canceled)
42-47. (canceled)
(canceled)
51-54. (canceled)
56-57. (canceled)
59-62. (canceled)
64-65. (canceled)
67-68. (canceled)
A pharmaceutical composition comprising a non-human antibody, or antigen binding portion thereof, and a reduced level of at least one impurity.
72-74. (canceled)
76-77. (canceled)
Dependencies are inferred from the claim text.